Johns Hopkins University, Pulmonary and Critical Care Medicine

Baltimore, Maryland 21205

0 studies enrolling now · 4 studies all time

What they study most

Combined Pulmonary Fibrosis and Emphysema, Interstitial Lung Disease, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Systemic Sclerosis-Associated PAH

Studies at this site

• A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) — Completed
• Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) — Completed
• Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1) — Stopped early
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed